New steroid hope for duchenne boys: safer muscle treatment?
NCT ID NCT05185622
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a drug called vamorolone in 54 boys with Duchenne muscular dystrophy, aged 2 to under 4 years and 7 to under 18 years. The goal was to check safety and how the body processes the drug over 12 weeks. Researchers hope vamorolone may help control the disease with fewer side effects than current steroids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
vamorolone
What this could lead to
If successful, vamorolone could offer a safer steroid option for managing Duchenne muscular dystrophy with fewer side effects.
What could go wrong
This is an early Phase 2 trial with only 54 participants, so results may not confirm effectiveness or safety for all. Side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alberta's Children Hospital
Calgary, Alberta, AB T3B 6A8, Canada
-
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
-
Montreal Childrens Hospital
Montreal, H4A 3J1, Canada
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada